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Exclusion of Integrins from CNS Axons Is Regulated by Arf6
Activation and the AIS
Elske H. P. Franssen,1* XRong-Rong Zhao,1* Hiroaki Koseki,1 XVenkateswarlu Kanamarlapudi,2
Casper C. Hoogenraad,3 Richard Eva,1 and JamesW. Fawcett1
1Cambridge Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 OPY, United Kingdom, 2Institute of
Life Science 1, College of Medicine, Swansea University, Singleton Park, Swansea SA2 8PP, United Kingdom; and 3Cell Biology, Faculty of Science, Utrecht
University, 3584 CH Utrecht, The Netherlands
Integrins are adhesion and survivalmolecules involved in axongrowthduringCNSdevelopment, aswell as axon regeneration after injury
in the peripheral nervous system (PNS). Adult CNS axons do not regenerate after injury, partly due to a low intrinsic growth capacity.We
have previously studied the role of integrins in axon growth in PNS axons; in the present study, we investigate whether integrin mecha-
nisms involved in PNS regenerationmay be altered or lacking frommature CNS axons by studyingmaturing CNS neurons in vitro. In rat
cortical neurons, we find that integrins are present in axons during initial growth but later become restricted to the somato-dendritic
domain. We investigated how this occurs and whether it can be altered to enhance axonal growth potential. We find a developmental
change in integrin trafficking; transport becomes predominantly retrograde throughout axons, but not dendrites, as neurons mature.
The directionality of transport is controlled through the activation state of ARF6, with developmental upregulation of the ARF6 GEF
ARNO enhancing retrograde transport. Lowering ARF6 activity in mature neurons restores anterograde integrin flow, allows transport
into axons, and increases axon growth. In addition, we found that the axon initial segment is partly responsible for exclusion of integrins
and removal of this structure allows integrins into axons. Changing posttranslational modifications of tubulin with taxol also allows
integrins into the proximal axon. The experiments suggest that the developmental loss of regenerative ability in CNS axons is due to
exclusion of growth-related molecules due to changes in trafficking.
Key words: Arf6; axon initial segment; axonal transport; integrin; trafficking
Introduction
During development, the role of axons is to extend toward their
targets. As they mature, the function of axons changes to neu-
rotransmission and there is a sharp decline in their intrinsic
growth capacity (Fawcett, 1992; Blackmore et al., 2012; Chish-
olm, 2013; Zou et al., 2013). As this happens, polarized distribu-
tion ofmanymolecules develops. Proteins for neurotransmission
reach the presynaptic axon terminal, whereas those intended for
postsynaptic functions are restricted to dendrites (Conde and Cac-
eres, 2009; Hirokawa et al., 2009; Rasband, 2010; Lasiecka and
Winckler, 2011; Farías et al., 2012). Integrins are growth and sur-
vival molecules that are important for axon growth during devel-
opment and for regeneration in the peripheral nervous system
(PNS) in adulthood (Werner et al., 2000; Vogelezang et al., 2001,
2007; Gardiner et al., 2005). During CNS development, they are
involved in axon growth and guidance (Huang et al., 2006;Myers
et al., 2011) and, in adulthood, they regulate aspects of synaptic
plasticity (McGeachie et al., 2011). In adulthood, there is an ab-
sence of integrins from mature CNS axons (Bi et al., 2001; Mor-
tillo et al., 2012). We hypothesize that exclusion of integrins and
other growth- and survival-relatedmolecules is the reason for the
lack of regenerative ability of mature axons.
Axon growth involves interactions between the cell surface,
signaling pathways, and the cytoskeleton. Integrins are an exam-
ple of membrane proteins involved in these processes, so their
study can reveal mechanisms that are important for axon growth
or regeneration and might indicate why the intrinsic growth ca-
pacity of CNS axons declines with maturity. Integrins are also
potential therapeutics: expression of an appropriate integrin or
its activator kindlin can enhance regeneration of adult PNS axons
into the CNS environment (Andrews et al., 2009; Tan et al.,
2012); however, this strategy will not work for CNS neurons be-
cause, like endogenous integrins, exogenous integrins are not
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transported into axons in mature CNS neurons in vivo (M.R.
Andrews and J.W.F., unpublished findings). We have therefore
investigated the mechanisms preventing axonal integrin traffic
with the aim of discovering ways to enable integrin transport into
mature CNS axons.
In previous work, we found that integrin trafficking in sensory
axons (which transport integrins) is mediated by two GTPases,
Rab11 and Arf6 (Eva et al., 2010, 2012), but these pathways and
integrin trafficking in general have not been studied in CNS axons.
We first examined integrin trafficking in rat brain cortical
neurons in vitro and found that integrins are restricted to the
somatodendritic compartment after the initial stage of axon
growth. A number of mechanisms contribute to the polarized
localization of membrane proteins in neurons (Conde and Cac-
eres, 2009; Hirokawa et al., 2009; Lewis et al., 2009; Rasband,
2010; Farías et al., 2012; Petersen et al., 2014). We have investi-
gated which of these regulates integrin localization and whether
manipulating them can restore integrin traffic. We find that the
main factors excluding integrins from axons are a developmental
shift to retrograde transport regulated by ARF6 that occurs
throughout the axon, cytoskeletal modifications, and additional
mechanisms associated with the axon initial segment (AIS). Ma-
nipulation of these mechanisms allows transport of integrin into
CNS axons and increases axon growth. We suggest that selective
exclusion of integrins and other growth-related molecules from
mature CNS axons is the main reason for the loss of regenerative
ability with maturity.
Materials andMethods
DNA constructs. Integrin 9 enhanced green fluorescent protein
(EGFP)-N3was obtained fromDean Sheppard (University of California,
San Francisco, CA). HA-p50 was a gift from Casper Hoogenraad (Utrecht
University,Utrecht, TheNetherlands;Hoogenraad et al., 2001). pcDNA3.1-
ACAP1-mycwas a gift fromVictorHsu (Department ofMedicine,Harvard
MedicalSchool,Boston,MA)andwasdescribedpreviously (Evaetal., 2012).
Myc-ARNO-E156K and GFP-ARNO-E156K were described previously
(Venkateswarlu and Cullen, 2000; Bouschet et al., 2007).
Immunostaining. Cell cultures on coverslips were fixed with either 4%
paraformaldehyde (PFA) for 10 min or ice-cold methanol for 5 min at
20°C and blocked for 30min in PBS containing 0.1%TritonX-100 and
2% goat serum. Cells were incubated with primary antibodies at 4°C
overnight, washed, and incubated with Alexa Fluor-conjugated second-
ary antibodies (Invitrogen) diluted 1:500 for 1 h at room temperature
beforemounting in Fluorsave (Millipore). For live labeling of91, cells
were incubated with primary antibody for 45 min at 37°C, fixed with
PFA, and incubated with secondary antibody. The following primary
antibodies were used: anti-integrin 1 clone EP1041Y (04-1109, 1:100;
Millipore), anti-integrin 5 (AB1928, 1:1000; Millipore), anti-integrin
V (AB1930, 1:1000; Millipore), anti-Ankyrin G (AnkG) clone N106/36
(1:100; NeuroMab), anti-neurofascin (clone A12/18, 1:200; NeuroMab),
anti-91 cloneY9A2 (ab27947, 1:200; Abcam), anti-tenascin-C (10337,
1:20; IBL), anti-MAP2 (AB5622, 1:300; Millipore), anti-Arf6 (ab77581,
1:500; Abcam), anti-ARNO (ab56510, 1:250; Abcam), anti-Rab11 (71-
5300, 1:50; Invitrogen), and anti-HA (clone 16B12, 1:400; Covance).
Polyclonal IV spectrin antibody (1:100) was kindly provided by Mat-
thew Rasband (Baylor College of Medicine, Houston, TX). Alexa Fluor
568-conjugated phalloidin (1:40; Invitrogen) was used to detect F-actin.
Fluorescent imageswere acquired using a LeicaDM6000microscope and
Leica LAS AF software.
Neuron cultures and transfection. Primary cortical neuron cultures
were prepared from embryonic day 18 (E18) rats. Neurons were dissoci-
ated with 0.1% trypsin (Invitrogen) for 15 min at 37°C, washed with
HBSS, and cultured in neurobasal medium (NB; Invitrogen) supple-
mented with B27 (Invitrogen), Glutamax (Invitrogen), glutamic acid
(Sigma), and PSF. Cells were plated on coverslips coated with poly-D-
lysine and 2 mg/ml laminin. 2 d in vitro (DIV) and 9 DIV neurons were
transfected by oscillating nanomagnetic transfection (magnefect nano
system; nanoTherics). DNA (1 g/well) was mixed with 1.8 l of mag-
netic nanoparticles (NeuroMag), incubated for 20min, and added to the
neurons in 500 l of NB. For cotransfection with 9-GFP and other
plasmids (ACAP1, ARNO, or P50), DNA used was 0.7g of the 9-GFP
and 0.7 g of the other plasmid mixed with the same amount of nano-
megnetic beads. All other procedures were kept the same. Plates were
incubated for 30 min at 37°C over magnetic arrays that were moving
laterally at 2 Hz and at 0.2 mm amplitude of displacement. After trans-
fection, 500l of the original culturemediumwas added to eachwell and
neurons were used for live imaging the next day.
Live-cell image acquisition and analysis. Live-cell imaging was per-
formed using spinning disk confocal microscopy, using an Olympus
IX70 microscope with a Hamamatsu EM-CCD Image-EM camera and a
PerkinElmer Ultra-VIEW scanner. Images were analyzed using Meta-
Morph software. To identify axons, neurons were live labeled with an
Alexa Fluor 594-labeled neurofascin antibody (clone A12/18, 1:200;
NeuroMab) for 45 min at 37°C. For antibody labeling, the Tris-
containing buffer of anti-neurofascin was first exchanged into 0.05 M
borate buffer by dialysis using a D-tube dialyzer (Novagen) and the an-
tibody was then fluorescently labeled using a DyLight 594 Antibody La-
beling Kit (Thermo Scientific). Axons were imaged at the AIS and just
beyond the AIS initially and then further analyzed at regions 100 m
into the axon and toward the end of axons (300–600mbeyond the cell
body). Dendrites were analyzed within the first 100 m of a primary
dendrite. Images were acquired every 3 s for a time period of 3 min and
kymographs were created to analyze direction of vesicle transport.
Vesicles were tracked for their visible lifetime and analyzed to deter-
mine the proportion ofmobile and immobile vesicles and the proportion
ofmobile vesiclesmoving anterogradely, retrogradely, or bidirectionally.
Vesicles with a totalmovement2mduring their visible lifetimes were
classed as immobile. Vesicles moving in both directions but with net
movement of 2 m (during their visible lifetimes) were classed as
bidirectional even though totalmovementmay have been larger. Vesicles
with netmovements2m in either direction by the end of their visible
lifetimes were classed as anterograde or retrograde accordingly.
Direction of transport of at least 110 vesicles per condition was ana-
lyzed from at least 20 neurons obtained from three or more individual
experiments. Statistically significant differences were calculated using
Fisher’s exact tests (pairwise comparisons for low numbers of vesi-
cles) and Mann–Whitney tests (comparison of ranks for high number
of vesicles).
Drug treatments. Neurons were treated after 14 DIV with Latrunculin
(LatA;Merck), tubulin deacetylase inhibitor trichostatin A (TSA; Sigma-
Aldrich) or Taxol (semisynthetic; Sigma-Aldrich). LatA and TSA were
added to the cells at a final concentration of, respectively, 2.5M and 250
nM. Cells were incubated with LatA for 2 h at 37°C and with TSA over-
night at 37°C. After treatment, cells were fixed and used for immuno-
staining. Neurons were treated with low-dose taxol (1 nM) for 3 h and
either fixed and used for immunostaining or used directly for live-cell
imaging. DMSO was used as a control for all drug treatments.
AnkG knock-down using adenovirus-mediated shRNA. The adenovi-
ruses were gifts fromDr.Matthew Rasband (Baylor College ofMedicine,
Houston, TX). E18 cortical neurons were infected at 3 DIV with adeno-
virus containing either AnkG shRNA or GFP as a control. Adenovirus
sense sequences for AnkG shRNA was 5-GCCGTCAGTACCATCT
TCT-3. Efficacy and specificity of these shRNA sequences were demon-
strated previously (Hedstrom et al., 2007) and production of the
adenovirus was as reported previously (Hedstrom et al., 2008).
Neurons were infected at 3 DIV for 3 h and then washed with warm
HBSS before changing back to the conditioned medium from the same
cells. After 72 h, cells were fixed with 4% PFA for 8 min at room temper-
ature (RT) followed by 100% methanol at RT for 3 min. The cells were
then immunostained for GFP, AnkG, or integrin 1.
Quantification of axonal and dendritic 1 integrin expression. 1 Integ-
rins were detected by immunofluorescence and images were acquired by
fluorescencemicroscopy using a LeicaDM6000Bmicroscopewith a 63
objective. To quantify 1 expression in axons, identical conditions for
immunostainings were used within each experiment and images were
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acquired with identical microscope settings. Axons were identified as
long and thin processes with positive AnkG staining. Cells with more
than one AnkG positive process were excluded. Experiments were re-
peated three times and, each time, at least 30 axons per group were
measured in each experiment. Dendritic fluorescence was quantified
similarly, measuring the average intensity of staining of all primary den-
drites of each cell analyzed.
Images were processed using ImageJ. Axons were traced with the free-
hand selection tool (line width 3). Fluorescence intensity of each pixel
along an axon was then obtained using the RGB Profiler plugin (Laum-
monerie and Mutterer, 2003) and data were analyzed in R (R Develop-
ment Core Team, 2008). After background subtraction (radius  50
pixel), fluorescent intensity was averaged for each 20 m segment along
the axon. Data from the three experiments representing the fluorescence
intensity at each location (distance from the beginning of axon initial
segment) were averaged and represented asmeans SEM at each 20m
segment. Statistical analysis was performed using two-way ANOVAwith
1 integrin fluorescent intensity as the dependent variable and treatment
condition and axon position as independent factors. ANOVA was fol-
lowed by Tukey’s HSD post hoc test chosen for its conservativeness in
comparing between groups.
Quantification of axonal length and branch number, and total dendritic
length. Axonal length was measured on the picture acquired using the
above-mentioned method. Total axon length was calculated by adding
together the lengths of each axon branch to the length of the primary
axon. This figure was used to represent the axon length for each neuron.
The axon was defined by the presence of AnkG or neurofascin staining.
Branching number was defined as the total branching points on an axon.
Data from each group were averaged and represented as means SEM.
One-way ANOVA and Tukey’s HSD post hoc test was used to compare
between groups. Total dendrite length was measured by adding together
the lengths of each of the primary dendrites per cell.
Results
The series of experiments that follow use integrins as a marker to
demonstrate amechanism for the loss of axon growth ability with
maturation. We show in the first two sections that integrins be-
come excluded from the axons of cortical neurons as the neurons
mature and that this is associated with a change in the direction-
ality of integrin transport, with integrins inmaturing axons being
transported retrogradely back to the cell body. We then test the
various mechanisms that have been proposed for selective trans-
port of molecules to the different parts of the neuron to find
which of these is responsible for excluding integrins from axons
and for switching transport to retrograde. Of the seven mecha-
nisms that we tested, we found two that are relevant. Readers who
wish to go directly to the positive results can skip to the sections
entitled “Is the axon initial segment a barrier to integrin entry
into axons?,” “Which component of the AIS restricts integrin
mobility?,” and “Does the activation state of Arf6, controlled by
GAPs andGEFs, change the directionality of transport in axons?”
The main conclusion is that integrins become excluded from
axons due to the properties of the axon initial segment and to
activation of the recycling endosome GTPase ARF6 by the GEFs
ARNO and EFA6, which switches integrin transport to retro-
grade. Forced inactivation of ARF6 restores anterograde trans-
port and enables increased axon growth.
Integrins are progressively excluded frommature CNS axons
To examine the presence and distribution of integrins in CNS
neurons, cortical neurons were immunostained for integrin 1
after being cultured for 1 d, 1 week, or 2 weeks (Fig. 1). Axons
were identified through staining for the AISmarker AnkG except
for day 1, when the AnkG was not yet expressed (Nakata et al.,
2003; Song et al., 2009) and the axon was identified by morphol-
ogy as the longest process. Early on (day 1, Fig. 1A–C), all pro-
cesses contained vesicles that stained for 1 integrin, these
molecules being uniformly distributed in the soma and all the
processes of the neurons. In more mature neurons cultured for 1
week, 1 integrin was present at a reduced level in axons, being
concentrated in the proximal 100 m, but the soma and den-
drites continued to contain many 1-integrin-positive vesicles
(Fig. 1D). After 2 weeks of culture, 1 integrin was still present in
the somatodendritic domain, but was excluded from axons be-
yond the AIS [see Figs. 1G, 4A (DMSO), 7A]. We also stained
maturing neurons for the  integrins 5 and V, finding the
same distribution. The two  integrins were present ubiqui-
tiously at 1 d in culture (Fig. 1B,C). By 7 DIV, the  integrins
were much reduced in the axons beyond the AIS (Fig. 1E,F).
These findings suggest that integrins are excluded from CNS ax-
ons as they mature and are consistent with previous in vivo ob-
servations (Bi et al., 2001; Mortillo et al., 2012).
Overall direction of integrin transport changes with
development
To gain some insight into how integrins traffic in CNS neurons
and how they might be excluded from axons, we first visualized
axonal integrin transport in real time.We transfected 9 and 2DIV
cortical neurons with GFP-tagged 9 integrin (9-GFP) and
used these neurons for live-cell imaging using spinning disc con-
focal microscopy at 10 and 3 DIV. We have focused on 9 integ-
rin because our previous work has shown that expression of 9
integrin in sensory neurons can enhance regeneration into the
spinal cord (Andrews et al., 2009), that 9-GFP targets correctly
in stable cell lines, and that it is functional upon overexpression
(Eva et al., 2010, 2012). To distinguish axons from dendrites
during live-cell imaging, we live-labeled the AIS with Alexa Fluor
594-conjugated anti-neurofascin (Fig. 2A). We initially analyzed
transport in the proximal part of the axon due to reports that the
initial segment can regulate the polarized distribution of certain
membrane proteins (Kobayashi et al., 1992; Bradke and Dotti,
2000; Nakata and Hirokawa, 2003; Song et al., 2009). Overex-
pressed 9-GFP was present in vesicles in axons at both 3 DIV
and at a lower level at 10 DIV. Vesicles were traced in the initial
segment and just beyond and their movements analyzed (Eva et
al., 2010, 2012). Each vesicle was classified as anterograde, retro-
grade, bidirectional, or immobile as described in the Materials
and Methods section. We observed a striking difference in the
overall direction of transport at the two time points (Movies 1, 2).
There was a considerable increase in the proportion of vesicles
transported retrogradely at 10 DIV (57%) compared with 3 DIV
(35%; Fig. 2B,C). However, anterograde transport changed little.
We also calculated the percentage of axons in which 0, 1, 2, 3, or
4 vesicles were moving anterogradely, retrogradely, or bidirec-
tionally or that were immobile. At 3DIV,most axons had either 0
or 1 retrograde vesicles, whereas, at 10DIV, themajority of axons
contained 2–4 retrograde vesicles (p  0.001). This contrasts
with vesicle movement in mature dendrites, in which antero-
grade and bidirectional transport wasmaintained (Fig. 2B,Movie
3). At 10 DIV, 70% of dendrites exhibited both anterograde
and retrograde transport andmany vesicles showed bidirectional
movement (Fig. 2C). We investigated axon transport more dis-
tally in axons. We analyzed transport at 10 DIV at two regions,
one region100 m into the axon and one region 300–600 m
beyond the cell body. At both of these regions, we found the same
prevailing retrograde transport that we observed in the initial
part of the axon (Fig. 2D,Movies 4, 5). These results demonstrate
that axonal integrins are mostly being transported back to-
ward the cell body at the time at which integrins are lost from
Franssen, Zhao et al. • Exclusion of Integrins from Axons J. Neurosci., May 27, 2015 • 35(21):8359–8375 • 8361
axons, but that transport into dendrites
is maintained. This retrograde transport
occurs both within the initial segment
and throughout the axon.
What mechanismsmight exclude
integrins frommaturing axons?
In the following sections, we have tested
various hypotheses that might explain the
exclusion of integrins from axons, and the
developmental change in their direction-
ality of transport. We have asked the fol-
lowing: (1) Is exclusion of integrins due to
lack of integrin subunit partners, prevent-
ing heterodimer formation? (2) Do integ-
rins leave axons because there is no ligand
in the environment? (3) Is the axon intial
segment a barrier to integrin entry into
axons? (4) If so, is this due to its dense
actin network or due to modifications of
tubulin? (5) Is the change in directionality
of transport due to competition between
anterograde and retrograde flow? (6)
Does recognition of binding sites on in-
tegrins by the mu1A subunit of the clath-
rin adapter protein-1 complex (AP-1)
direct integrins away from axons? (7)
Does the activation state of Arf6, con-
trolled by GAPs and GEFs, change the di-
rectionality of transport in axons?
Is exclusion of integrins due to lack of
integrin subunit partners, preventing
heterodimer formation?
Inability to form heterodimers due to lack
of partners was excluded for two reasons.
First, both and thematching1 integrin
subunits are present in the somatoden-
dritic domain at the time when they are
being excluded from axons (Fig. 1). Sec-
ond, we used an antibody that recognizes
only the 91 dimer but neither subunit
individually. In neurons transfected with
9 integrin, 91 heterodimers were
present (Fig. 2E).
Do integrins leave axons because there is
no ligand in the environment?
This argument is unlikely because all neuro-
nalprocesses share the sameenvironment in
vitro, yet integrin is only excluded from
axons. To comfirm the presence of the li-
gand in our cultures, we immunolabeled
tenascin-C (ligand for 91 integrin) and
demonstrated that it is distributed exten-
sively throughout thecultures,most likelyas
a result of astrocyte secretion (Fig. 2F).
Is the axon initial segment a barrier to
integrin entry into axons?
Because of the sharp cutoff of endogenous
integrins at the AIS, we investigated
whether the AIS might form a barrier to
integrin transport into axons, as was pre-
Figure1. Integrins are not transported into the axons ofmature CNSneurons.A–C, At 1DIV, various types of integrins (1,5,
andv) are distributed ubiquitously in cell bodies and neurites.D, At 7 DIV, the1 integrin level is gradually reduced in axons and
dendrites. At 1 week (E, F ),  integrins are restricted to the somatodendritic domain and absent in axons. At 2 weeks (G), 1
integrins disappear from axons too. Scale bars: A–C, 25m; D–G, 50m.
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Figure 2. InmatureCNSaxons,9-GFPvesicles are retrogradely transported to the cell body.A, Day10 cortical neuron transfectedwith9-GFPwas stainedwithNeufascin to identify theaxon,where the
vesiclemovementwas imaged.Transfected9-GFPsareslightlymissorted,withmore integrinmolecules found in theaxons.Scalebar,25m.B, Kymographsof9-GFPvesicles traffic inaxonsat10DIV(left)
and 3DIV (middle) and in a dendrite at 10 DIV (right). In axons, less retrograde transportationwas observed in younger cultures comparedwith 10 DIV cultures; in dendrites, vesicleswere transported in both
directions at 10 DIV. C, From 3 to 10 DIV (left), the overall percentage of retrogradelymoving vesicles increases; a greater percentage of axons were observed to contain retrogradelymoving vesicles and the
number of vesicles increased as axonsmature (middle; ***p 0.001,Mann–Whitney test); in dendrites at 10DIV, no significant differencewas observed betweennumber of anterogradely and retrogradely
moving9vesicles (right).D, Kymographsandanalysisof9-GFPvesicle traffic inaxonsat10DIVata region100mintotheaxon(proximal)andtowardtheendof theaxon(distal,300–600m).E,91
dimerwas formed in neurons transfectedwith9-GFP. F, Neuron cultures produce tenascin-C on the substrate. Scale bars, 50m.
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viously suggested as a mechanism of polarized distribution (Ko-
bayashi et al., 1992; Bradke and Dotti, 2000; Nakata and
Hirokawa, 2003; Song et al., 2009). We also wondered whether
interfering with the AIS might enhance axon growth potential.
We first demolished the AIS by reducing expression of AnkG,
which is essential for AIS integrity. We used a well characterized
adenovirus expressing a GFP-shRNA construct to silence AnkG,
which has been previously validated in neurons (Hedstrom et al.,
2007, 2008). We transduced cortical neurons at 3 DIV and, by
72 h, AnkG was no longer detectable by immunostaining in
90% of the GFP-positive cells (Fig. 3A). After AnkG knock-
down, we could no longer identify axons using AIS neurofascin
labeling, so for measurements of integrin distribution, we se-
lected neurons with an obvious single long process with axonal
morphology and shorter tapered dendrites. 1 integrin levels
were measured using immunostaining as a ratio of GFP level.
Neurons lacking AnkG showed a significant increase of integrin
1 in axons (AnkG silenced vs GFP group is 3.917  0.369 by
Tukey post hoc analysis, p  0.001) and it was detectable much
farther along the axons compared with GFP controls transduced
by the same adenovirus (Fig. 3B–D). However, admission of in-
tegrins to the proximal part of the axons was not sufficient to
increase axon growth in our cultures. At 7 DIV, the length of
control GFP axons was 393.7  77.14 m, whereas the AnkG
knock-down axons averaged 430.2  94.33 m (p  0.205 by t
test). We found some endogenous integrins on the surface of
axons after silencing of AnkG, as well as within the axons, sug-
gesting that they have been inserted into the membrane, but also
raising the possibility that some of this entrymay be due to lateral
diffusion within the surface membrane. Our results suggest that
the AIS exerts some control over the entry of integrins into the
axon, but that its removal does not allow for increased axon
growth.
Which component of the AIS restricts integrin mobility?
Having established that the AIS plays a role in the polarized dis-
tribution of integrins in neurons, we asked how it might do so.
The barrier is proposed to act in two main ways: by the dense
actin network or through posttranslational modifications to tu-
bulin in the AIS. To determine whether an intact actin cytoskel-
eton plays a role in impeding integrin transport into axons,
Movie 1. Inmature cortical neurons,9 integrin vesicles are retrogradely transported from
axon to cell body. Cortical neuronswere transfectedwith9-GFP (green) and live-imagedat 10
DIV for 3 min. Axons were identified by neurofascin live staining in red at the AIS (Fig. 6).
Movie 2. In young cortical neurons,9 integrin vesicleswere not transported back fromaxon to
cell body. Cortical neuronswere transfectedwith9-GFP (green) and live-imagedat 3DIV for 3min.
Movie 3. Inmature cortical dendrites,9 integrin vesicles traffic in both directions. Cortical
neurons were cotransfected with9-GFP, and dendrites were live-imaged at 10 DIV.
Movie4. Live imaging of9-GFP vesicle traffic in axons at 10DIV at a region proximal to the
cell body, typically 100m into the axon.
Movie 5. Live imaging of9-GFP vesicle traffic in axons at 10 DIV at a region distal from the
cell body. This was performed at a region as far into the axon as could be traced by 9-GFP
signal, typically 300–600m into the axon.
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neurons were treated with the actin-filament disrupter LatA or
DMSO. After treatment with LatA, staining with phalloidin
showed substantial disruption of actin filaments (Fig. 3E). We
found a small but significant increase in the 1 integrin level by
immunostaining in the region of the AIS (p 0.002; Fig. 3F–H).
LatA treatment also led to a small reduction in integrin fluores-
cence in dendrites, although this was not statistically significant
(fluorescence of 11.58 arbitrary units  0.54 SEM for taxol-
treated neurons, compared with 12.42 0.28 for DMSO-treated
controls, p  0.176, Student’s t test). We can conclude that dis-
rupting the actin network partially releases the blockade of integ-
rin transport, but only into the initial part of CNS axons.
Next, we investigated whether posttranslational modifica-
tions (PTMs) of microtubules (MTs) are involved in polarized
integrin distribution. PTMs have been shown to provide infor-
mation for directional transport. For example, kinesin-1 prefer-
entially accumulates in axons, particularly at the tip (Nakata and
Hirokawa, 2003), and the kinesin kif3C accumulates in growth
cones influenced by tubulin tyrosination and other factors
(Gumy et al., 2013). Low-dose taxol changes the location of sev-
eral PTMs and has been shown to disrupt the selective location of
kinesin-1 and kif3C (Hammond et al., 2010; Gumy et al., 2013).
Neurons were treated with low-dose taxol (1 nM) or DMSO for
3 h and endogenous 1 integrin was measured in axons by im-
munostaining. After taxol treatment, there was a significant in-
crease in 1 integrin in the first 150 m of the axon (3.149 
0.697 arbitrary units, p  0.001, Tukey post hoc analysis; Fig.
4A,B). Taxol treatment led to a small reduction in integrin fluo-
Figure 3. Disruption of the AIS increased1 integrin expression in axons. A, Adenovirus-mediated delivery of AnkG shRNA resulted in silencing of AnkG in cortical neurons 72 h after infection.
B–D, At 72 h after transduction, integrin1 level is increased in axon (C) comparedwith GFP control (B) by 3.917 0.369 units ( p 0.001, group difference by Tukey post hoc;D). E, LatA results
in disruption of actin filaments (phalloidin staining) and results in a small but significant increase in1 integrin level in the axons (F–H; p 0.002). Note that the experimental proceddures of LatA
treatment and AnkG knock down were very different, the measurements are not to be compared between experiments. Scale bars, A-C, 25m. E–G, 50m.
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rescence in dendrites compared with DMSO-treated controls,
although this was not statistically significant (fluorescence of
13.33 arbitrary units 0.47 SEM for taxol-treated neurons com-
pared with 14.43 0.45 for DMSO-treated controls, p 0.0947,
Student’s t test). PTMs within the AIS therefore exert some con-
trol over the entry of integrins into axons but, again, this is only
apparent within the initial part of the axon. Altering PTMs with
taxol does not allow for integrin transport into the distal part of
the axon.
We then investigated whether taxol changes integrin vesicle
traffic direction. 9-GFP-transfected neurons were treated with
taxol and subjected to live-cell imaging of the proximal part of the
axon. In 10 DIV neurons, which normally show predominantly
retrograde integrin flow, we found that taxol treatment increased
anterograde transport—72.5% of the taxol-treated neurons have
3 or more vesicles transported anterogradely in axons during the
3 min observation period, compared with none in the control
neurons (p  0.01)—and decreased retrograde transport—
42.5% contain retrogradely transported vesicles in the taxol-
treated samples compared with 100% in the control group (p
0.002; Fig. 4E,F). Axon growth measured at 10 DIV showed no
effect of taxol treatment (639.1 91.8 forGFP vs 672.2 81.4 for
GFP	 taxol).
Due to its multiple effects on PTMs, it is rarely possible to
identify which of the many effects of taxol is responsible for a
particular change (Janke and Bulinski, 2011). However, taxol in-
creases acetylation and increased acetylation by tubulin deacety-
lase inhibitor TSA influences kinesin localization (Hammond et
al., 2010). We tested whether TSA would alter integrin transport
in a similar fashion to taxol, however we did not observe a signif-
icant effect (p 0.564; Fig. 4C,D). Together, these results suggest
the AIS plays a part in the exclusion of integrins from axons and
that local tubulin PTM of axonal MTs are involved in this exclu-
sion through influencing the distribution and directionality of
transport of 1 integrin. It is probable that a combination of
tubulin PTMs is involved.
Is the change in directionality of transport due to an imbalance
between anterograde and retrograde flow?
To answer this question, we first had to find themolecule respon-
sible for retrograde transport of integrins; we hypothesized that it
is mediated by dyneins. To test this, we inhibited dynein function
by overexpressing HA-tagged dynamitin/p50, which results in
dissasembly of dynactin, a complex that mediates the binding of
dynein to its cargo (Burkhardt et al., 1997;Melkonian et al., 2007;
Kapitein et al., 2010). Neurons were cotransfected with 9-GFP
and p50-HA; the cotransfection was confirmed by fixing and
labeling with anti-HA (Fig. 5A).We found that inhibiting dynein
function almost completely abolished retrograde transport of
9-GFP vesicles in axons (p 0.001) and the number of immo-
bile vesicles increased compared with cells expressing 9-GFP
only (p 0.02; Fig. 5C,D, Movie 6). This suggests that the retro-
Figure 4. Tubulin PTM modification results in increased axonal1 integrin. A, B, Low-dose taxol treatment increased1 integrin level in the axons with group difference of 3.149 0.697
arbitrary units ( p 0.001). C,D, TSA-induced increased acetylation did not increase1 integrin level in the axons. E, F, Taxol treatment increased9-GFP vesicle anterogrademovement. **p
0.01; *p 0.05. Scale bars in A–C, 25m.
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grade transport of 9-GFP vesicles in axons is mediated by dy-
neins. However, there was no change in anterograde transport
after retrograde transport suppression (Fig. 5D), suggesting that
the change in the directionality of integrin transport with neuro-
nalmaturity is not due to a change in the balance of a competition
between anterograde and retrograde transport machinery.
Does recognition of binding sites on integrins by AP-1-mediated
sorting mechanisms direct integrins away from axons?
Recent work has demonstrated that the distribution of some
transmembrane receptors between the axonal and somatoden-
dritic compartment is determined by the recognition of signals
within the cytosolic domains of the proteins interacting with the
mu1A subunit of the AP-1 complex (Margeta et al., 2009; Farías
et al., 2012). Examination of the intracellular domains of integ-
rins shows integrin subunits  3, 4, 5, 7, and 9 contain a potential
YXX
motif that could potentially recognize AP-1. The intracel-
lular domain of integrin 1 has two NPXYmotifs independently
involved in endocytic sorting and traffic (Margadant et al., 2012;
Steinberg et al., 2012).
We used a previously validated mutated dominant negative
form of the AP-1 mu1 subunit (Farías et al., 2012) to investigate
whether this mechanism is involved in the exclusion of integrins
from axonal transport. Day 9 primary cortical neurons were
transfected with mutated AP-1 mu1 (mu1-W408S) subunit (Fig.
6A,C) or the wild-type (WT) form (Fig. 6B,D). High levels of
expression were seen on the following day, neurons were then
fixed and stained to measure the distribution of endogenous in-
tegrin 1 (Fig. 6A,B) or 5 (Fig. 6C,D) in axons identified by
neurofascin staining.We found no difference in the integrin level
in axons of neurons expressing mu1-WT or mu1-W408S (Fig.
6E), indicating that direction by the NPXY motifs on the 1 tail
Figure5. Retrograde transport of9-GFP in axons ismediatedbydyneins.A, Neuronswere cotransfectedwith9-GFP andp50-HA. Scale bar, 30m.B, Axonswere identifiedwithNeurofascin
live staining. C, D, Inhibiting dynein function resulted in an abolishment of retrograde transport but increased immobile vesicles ***p 0.001; **p 0.01.
Movie 6. Interfering with dynein stops9 integrin retrograde transportation inmature cortical
axons. Cortical neuronswere cotransfectedwith9-GFP andHA-p50 and live-imaged at 10DIV.
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are probably dominant overAP-1-dependent sorting for the restric-
tion of integrin transport into axons. This finding and highlights the
probability that there are several mechanisms regulating the polar-
ized distribution of membrane proteins in neurons.
Does the activation state of Arf6, controlled by GAPs and GEFs,
change the directionality of transport in axons?
In adult DRG axons, there is no block of integrin transport into
axons.Many of the vesicles that contain integrin aremarked with
the GTPase Arf6 and manipulation of the activation state of Arf6
alters the direction of integrin transport, with activation by GEFs
promoting retrograde transport and reduced axon growth,
whereas inactivation by GAPs had the opposite effect (Eva et al.,
2012). We hypothesized that Arf6 activation/inactivation might
have a similar effect on the direction of integrin transport in CNS
axons.
We first visualized the presence and distribution of Arf6 in
cortical neurons by immunostaining, finding it in axons and den-
drites at both 2 and 14DIV (Fig. 7A). Conversely, theGEFARNO
was barely detectable at 2 DIV, but was strongly labeled in den-
drites and throughout the axon at 14 DIV, as indicated by the
absence of the dendritic marker MAP2 (Fig. 7B). Expression of
another Arf6 GEF, EFA6, also increases with development (Sak-
Figure 6. AP-1-dependent somatodendritic sorting is not themainmechanism for integrin axonal exclusion. Cortical neurons were transfectedwithWT (A, C) and themutated (B,D) AP-1mu1
subunit and the integrin level was measured in axons with1 (A, B) and5 (C, D). Arrows point to the AIS, which is stained with AnkG in blue and is used to identify axon branches. E, Expression
of mutated AP-1 did not increase the concentration of1 or a5 integrins in axons and did not allow integrin5 to enter the axon far beyond axon initial segments. Scale bars, 25m.
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agami et al., 2006). Interestingly, we also found that Rab11 was
largely excluded frommature axons, being present at low levels in
axons compared with dendrites in 14 DIV neurons (Fig. 7C).
We then manipulated Arf6 activity in 9 DIV neurons by ex-
pressing constructs that alter Arf6 activation. ACAP1 is an Arf6
GAP that inactivates Arf6 and favors anterograde integrin trans-
port when overexpressed in sensory neurons (Eva et al., 2012);
ARNO-E156K (a catalytically inactive form of ARNO) also inac-
tivates Arf6 with similar effects. However, thesemolecules do not
simply affect ARF6 activation; ACAP1 also functions as a coat
protein and ARNO associates with trafficking-related scaffolding
molecules and paxillin (Li et al., 2007, Mo et al., 2012, Torii et al.,
2010). These constructs were cotransfected with9-GFP to allow
live imaging and analysis of axonal traffic. Cotransfection was
confirmed afterward by fixing and labeling for the epitope tag
(Fig. 7D). Axons were identified with anti-neurofascin-594.
Quantification of the direction of transport of 9-GFP vesi-
cles showed that ACAP1 transfection resulted in a large increase
in the percentage of axons containing vesicles moving in an an-
terograde direction (44% compared with 9% in cells with 9-
GFP alone, p 0.04) and less with retrograde transport (52% vs
95% in 9-GFP alone, p 0.002; Fig. 7E–G, Movie 7). Similar to
overexpression of ACAP1, overexpression of ARNO-E156K re-
sulted in increased anterograde (53% of neurons vs 9% in con-
trols, p  0.003) and decreased retrograde transport (87% of
neurons vs 95% in controls, p  0.001; Fig. 7E–G, Movie 8).
ACAP1 and ARNO-E156K not only changed the overall percent-
age of vesicles moving anterogradely and retrogradely (Fig. 7F),
but also the percentage of axons containing multiple vesicles
moving in either direction (Fig. 7G). Interestingly, overexpres-
sion of ARNO-E156K also resulted in an increased percentage of
axons showing no immobile vesicles (Fig. 7G). This might suggest
Figure 7. Direction of axonal integrin transport in mature CNS axons is controlled by ARF6. A, ARF6 was present in axons and dendrites of neurons at both 2 and 14 DIV. B, ARNO is increased in
axons and dendrites of 14DIV neurons compared with 2 DIV and is expressed throughout the axon (MAP2 negative). C, Rab11 is present in dendrites but not in axons of 14 DIV neurons. D, For live
imaging, neuronswere cotransfectedwith9-GFPandeitherACAP1-mycorARNO-E156K-mycandaxonswere identifiedwithneurofascin.E,F,G, Kymographs andanalysis of9-GFPvesicle traffic
in control axons or after transfection with ACAP1, ARNO-E156K, or ARNO-E156K combined with taxol treatment. ***p 0.001; **p 0.01; *p 0.05.
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that overexpressionofARNO-E156K forces immobile vesicles in the
axons tomove anterogradely. Combining ARNO-E156Kwith taxol
further increased the percentage of anterograde-transporting ves-
icles compared with ARNO-E156K alone from 36% to 57% (p
0.028, Mann–Whitney test; Fig. 7E–G, Movie 9). These results
suggest that modulation of ARF6 by the two GEFS ARNO and
EFA6 is probably responsible for the developmental change from
bidirectional to retrograde flow of integrin. Transfection with
ACAP1 and ARNO-E156K will reverse the activation of ARF6,
but will also have other effects due to the coat protein actions of
ACAP1 and the interactions of ARNO with trafficking-related
scaffolding proteins and paxillin (Mo et al., 2012, White et al.,
2010).
We then investigated whether changing the direction of trans-
port could result in increased localization of endogenous integ-
rins to maturing axons and if the changes could result in an
enhancement of axon growth. We chose to do this using ARNO-
E156K either alone or in conjunction with taxol treatment. We
measured endogenous integrin 1 in axons transfected with
ARNO-E156K in the presence or absence of taxol. Nine DIV
cortical neurons were transfected with GFP, ARNO-E156K, or
ARNO-E156K combined with taxol (Fig. 8A–C). ARNO-E156K
expression resulted in a significant increase in axonal integrin
compared with GFP controls, with an overall difference of
3.168  0.362 units (p  0.001; Fig. 8D). Combining ARNO-
E156K and taxol treatment increased the difference to GFP con-
trol to 6.223 1.436 units (p 0.001) and to the ARNO-E156K
alone group in the initial 200 m (t 0.00269, paired t test; Fig.
8D). Importantly, this increase in integrin transport was also as-
sociated with an increase in axon growth (903  146 vs 694 
134, ARNO-E156K vs GFP, t  0.001, unpaired t test; Fig. 8E),
but not the branching number (6.48  1.13 vs 5.83  1.06, t 
0.384). The combination with taxol did not further increase axon
length. Overexpression of WT ARNO did not produce any sig-
nificant change in integrin level or axon length compared with
controls, with integrin excluded from axons (data not shown).
Expressing ARNO E156K also had an effect on dendrites, leading
to shorter dendrites comparedwithGFP-expressing controls (to-
tal ARNO E156K dendrite length 399.2 20 m compared with
498.2 15.1 for GFP expressing controls, p 0.001, Student’s t
test). They also had more primary dendrites per cell (average
number of 8 0.29 for ARNO E156K compared with 5.3 0.2
for controls, p 0.0001, t test). Neurons expressing ACAP1 also
had shorter dendrites compared with GFP-expressing controls
(total ACAP1 dendrite length 287.4  12.3 compared with
510.2 15.9 for GFP-expressing controls, p 0.0001, Student’s
t test), although there was no difference in the number of primary
dendrites per cell between the two groups.
Putting these findings together, we found that, as with sensory
axons, the overall direction of integrin transport in CNS axons is
controlled by the activation state of Arf6. Forced inactivation of
ARF6 causes an increase in anterograde transport of 9-GFP
vesicles, higher integrin levels, and increased axon growth. For
PC12 cells growing on tenascin-C, the effects of ARF6manipula-
tions were 9 integrin dependent (Eva et al., 2012), but in the
present experiments with axons growing in a complex environ-
ment, it is likely that some of the other growth-related molecules
transported in ARF6 vesicles may also be important.
In summary, integrins are excluded from axons by the prop-
erties of the AIS, with posttranslational modifications to tubulin
playing a part, and by the developmental change in the overall
direction of integrin transport driven by ARF6 activation. Inac-
tivation of ARF6 restores integrin transport to distal cortical ax-
ons and increases axon growth.
Discussion
Our experiments demonstrate a developmental change in neuro-
nal integrin trafficking, leading to the exclusion of integrins from
cortical axons after the initial phase of axon growth. This change
Movie 7. Overexpression of ARF6 GAP ACAP1 increases anterograde transportation and de-
creases retrograde transportationof9 integrin inmature cortical axons. Cortical neuronswere
cotransfected with9-GFP and ARF6 GAP ACAP1-myc.
Movie 8. Interfering with ARF6 GTP by overexpressing ARNO-E156K increases anterograde
transportation anddecreases retrograde transportation of9 integrin inmature cortical axons.
Cortical neurons were cotransfected with9-GFP and a catalytically inactive form of ARF6 GEF
ARNO, ARNO-E156K.
Movie 9. Combining ARNO-E156K and taxol further increases anterograde transportation of
9 integrin in mature cortical axons. Cortical neurons were cotransfected with9-GFP and an
ARNO-E156K and treated with taxol.
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Figure 8. ARNO-E156K significantly increased integrin level in axons as well as axon length. A, In day 9 cortical neurons transfected with GFP, integrin1 was absent in axons beyond the AIS
(stainedwith AnkG).B, Overexpression of ARNO-E156K increased1 integrin level in axons including in the distal part (ii,iii). C, Combination of ARNO-E156Kwith taxol treatment showed a similar
effect.D, Integrin1 fluorescent intensity in axons is increasedwith ARNO-E156K or the combination treatment (ARNO-E156K vs GFP: 3.168 0.362; ARNO-E156K	 taxol vs GFP: 6.223 1.436;
p 0.001 in both cases). Compared with ARNO-E156K alone, the combination increased integrin1 in the proximal 200m (t 0.0027, paired t test), but not in the distal part. E, ARNO-E156K
significantly increased axon length; combination with taxol had no additional effect. ***p 0.001. Scale bars in A–C, 50m.
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affects axon growth and suggests amechanism that contributes to
the developmental loss of intrinsic axon growth potential in ma-
ture CNS axons.
Mechanisms of integrin transport
Integrins traffic in vesicles marked by GTPases that regulate ves-
icle behavior. These mechanisms are well understood in cancer
cells, the migration and invasion of which involve integrins (Ar-
jonen et al., 2011; Margadant et al., 2011). We previously inves-
tigated integrin trafficking in adult sensory neurons (which
transport integrins in both central and peripheral branches) and
found that integrin trafficking shares similar mechanisms to can-
cer cells (Eva et al., 2010, 2012). Integrins associate with vesicles
marked by Rab11 and ARF6, which regulate integrin trafficking
in the growth cone and in axons. Rab11 vesicles undergo mainly
short rangemovements, whereas for long-range transport, integ-
rins are in vesicles regulated by ARF6. We now find both Rab11
andARF6 are present in cortical neurons, although axonal Rab11
levels decline with maturation and it becomes principally local-
ized to dendrites. We demonstrate that ARF6 regulates a mecha-
nism that leads to predominantly retrograde transport of
integrins away from axons as they become more mature. Retro-
grade transport is dynein dependent because blocking dynein
with dynamitin/p50 stops retrograde flow of integrin vesicles.
Mechanisms of selective localization in neurons
Many molecules, including some glutamate receptors, various
postsynaptic proteins, transferrin receptor, MT-associated pro-
tein MAP2, and others, are restricted to the somatodendritic do-
main inmature neurons (Dotti andPoo, 2003; Farías et al., 2012).
Several mechanisms have been demonstrated for selective lo-
calization of molecules. The AIS of CNS neurons may act as a
selective transport filter, preserving neuronal polarization by re-
stricting diffusion of proteins between the somatodendritic and
axonal domains (Kobayashi et al., 1992; Winckler et al., 1999;
Dotti and Poo, 2003; Nakata and Hirokawa, 2003; Song et al.,
2009; Farías et al., 2012). The AIS exhibits a dense network of
actin, which can restrict access to axons by acting as size filter or
by supporting retrograde myosin-driven transport (Arnold,
2009; Lewis et al., 2009; Song et al., 2009) and actin is also impor-
tant for directing molecules to dendrite or axon-directed vesicles
(Petersen et al., 2014). The AIS also has cross-linked and tyrosi-
nated MTs (Rasband, 2010). PTMs of MTs at the AIS and else-
where can alter the distribution of kinesins (Hammond et al.,
2010; Nakata et al., 2011; Gumy et al., 2013). Different cargos are
linked to different kinesins, several of which are developmentally
regulated, and the distribution of cargo is therefore influenced by
the type of kinesin and the cargo (Huang and Banker, 2012; Na-
kata et al., 2011; Heintz et al., 2014). Subcellular localization of
some molecules in many cell types, including neurons, is influ-
enced by adaptor proteins such as AP-1, with the mu1A subunit
of AP-1 being implicated in localization in neurons (Farías et al.,
2012). The balance between anterograde and retrograde trans-
port can determine localization into neuronal dendrites
(Kapitein et al., 2010). Our studies were designed to find out
which of these possible mechanisms is responsible for the ex-
clusion of integrins from mature cortical neurons.
Why do integrins become excluded from axons?
In the cortical neurons that we studied, integrins were initially
evenly present in all the neuronal processes, but from 7 DIV
onward, they became progressively excluded from axons, re-
maining present in the soma and dendrites. Because the distribu-
tion of integrins showed an anatomical cutoff at the AIS, an
obvious hypothesis was that this structure is a barrier to integrin
transport. We found direct evidence for this when we disrupted
the AIS through knock-down of AnkG, which allowed integrin to
enter the axons and to be transported for a considerable distance
along their length.We then investigated whether the AIS filtering
could be ascribed to the actin or tubulin components within it.
We found evidence for a minor role of the actin cytoskeleton,
disruption of which admitted an increased amount of integrin
into the initial segment, as seen also for the transferrin receptor
(Petersen et al., 2014). However, modification of the MTs had a
greater effect, with low-dose taxol treatment allowing integrins
into the initial segment and proximal axon. Taxol has many ef-
fects on MTs, including on acetylation, tyrosination, and poly-
glutamylation (Hammond et al., 2010; Nakata et al., 2011; Kee et
al., 2012). Increasing acetylation with a deacetylase inhibitor did
not have the same effect. Low-dose taxol treatment can enhance
axon regeneration over inhibitory substrates both in vitro and in
vivo (Mansfield and Gordon-Weeks, 1991; Hellal et al., 2011).
This has been ascribed to its effects on MT dynamics, but our
results suggest that an effect on transport may also be significant.
For somemolecules that are restricted to the somatodendritic
compartment, compartmentalization relies on the adaptor pro-
tein AP-1 and clathrin (Margeta et al., 2009; Farías et al., 2012).
Adaptor proteins such as AP-1 recognize cargos via a YXXØ
(present in some  integrins) or [DE]XXXL[LI] motif (Bonifa-
cino and Traub, 2003; Caster et al., 2013; Ren et al., 2013); how-
ever, we did not find evidence that the mu1A subunit of AP-1
controls integrin distribution. Integrin trafficking is also directed
by the two NPXY motifs on the intracellular tail of 1 and other
 chains, which bind competitively to many ligands (Legate and
Fassler, 2009, Morse et al., 2014). Our results suggest that traf-
ficking direction by the  chain is dominant over the  chains.
However, we believe that the main mechanism for selective
integrin distribution is through regulation of trafficking via the
small GTPase ARF6. That this type of mechanism controls the
selective distribution of integrin was suggested when we found
that, as cortical axons mature, the overall direction of integrin
transport changes to predominantly retrograde in axons, but not
in dendrites. It seems probable that this predominantly retro-
grade movement empties the axons of integrin and excludes in-
tegrin entry. Our previous work in sensory axons has shown that
rapid transport occurs in vesiclesmarked byARF6.Moreover, the
activity of ARF6, controlled by balanced activity of GAPs and
GEFs, affects vesicle transport direction. Activation of ARF6 by
GEFs favors retrograde axon transport and internalization at the
growth cone, whereas inactivation by GAPs has the opposite ef-
fect (Eva et al., 2012). We found evidence that this switch also
controls the direction of transport in cortical neurons. Develop-
mental activation ofARF6byGEFs is responsible for the switch to
retrograde flow and anterograde flow and axon growth can be
restored by overexpressing a GAP or the dominant-negative GEF
ARNO-E156K. During cortical neuronal maturation, two ARF6
GEFs, ARNO and EFA6, are strongly upregulated (Sakagami et
al., 2006) and our findings suggest that developmental upregula-
tion of these two GEFs is involved in excluding integrins from
axons. A number of GEFs and GAPs localize to dendrites (Scholz
et al., 2010; Oku and Huganir, 2013). Interestingly, in DRG neu-
rons, we have found that ARNO mRNA is preferentially ex-
pressed in embryonic rather than adult neurons (Gumy et al.,
2011).
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ARF6 and axon growth
Axon growth involves the coordination of many processes, in-
cluding the transport, internalization, and recycling of integrins.
In these processes, ARF6 is involved at several stages, including
recruitment of coat proteins and effector molecules, generation
of phosphoinositides and phosphatidic acid, clathrin-mediated
events, and polarized delivery of other GTPases (Herna´ndez-
Deviez et al., 2004, 2005, 2007; Bouschet et al., 2007). ARF6GAPs
and GEFs, can also act as scaffolds for the assembly of signaling
complexes (for review, see Donaldson and Jackson, 2011).
ACAP-1 also associates directly with 1 integrin and, together
with Rab11 andARF6, participates in its recycling (Powelka et al.,
2004; Li et al., 2005). ARNO associates with various scaffolds and
with paxillin (Mo et al., 2012, Torii et al., 2010, White et al.,
2010). In sensory axons, the balance of ARF6 GAPs and GEFs
translates to effects on axon growth, with ARF6 inactivation by
GAPs increasing growth (Eva et al., 2012). Our findings in corti-
cal neurons now show that a similar mechanism operates in CNS
axons. However, in the CNS, the developmental activation of
ARF6 by GEFs leads to the exclusion of integrins from axons by
favoring retrograde transport. This mechanism likely involves an
interaction between the scaffolding molecules JIP3 and JIP4,
ARF6, and kinesin and dynein motors (Isabet et al., 2009; Suzuki
et al., 2010; Montagnac et al., 2011).
CNS axon regeneration
Axons will only regenerate if they are equipped with the appro-
priate machinery. Our results show that CNS axons lack at least
one critical component, integrins. Sensory axons transport integ-
rins and, if transduced to express 9 integrin and the activator
kindlin-1, can regenerate profusely in the spinal cord (Andrews et
al., 2009, Tan et al., 2012, Cheah et al., 2013). However, 9 integ-
rin expressed in cortical neurons in vivo does not enter axons.We
have identified mechanisms that exclude integrins from cortical
axons. These may also exclude additional molecules that affect
axonal regenerative ability, including ribosomal protein, which is
excluded fromCNS retinal axons, diminishing their regenerative
ability through local translation (Verma et al., 2005), and trkB,
which is excluded from corticospinal axons (Hollis et al., 2009).
Overall, it seems probable that the poor intrinsic regenerative
performance of CNS axons is partly due to the exclusion of key
growth-related molecules.
Notes
Supplemental material for this article is available at www.brc.cam.ac.uk.
This material has not been peer reviewed.
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